References
- Abbasi A N, Zahid S, Bhurgri Y, et al (2011). Nasopharyngeal carcinoma - an update of treatment and acute radiation induced reactions from a tertiary-care hospital in Pakistan. Asian Pac J Cancer Prev, 12, 735-8.
- Cao P, Zhou L, Zhang J, et al (2013). Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma. Head Neck, 35, 720-8. https://doi.org/10.1002/hed.23011
- Chen H C, Chen G H, Chen Y H, et al (2009). MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br J Cancer, 100, 1002-11. https://doi.org/10.1038/sj.bjc.6604948
- Fu X, Tian J, Zhang L, et al (2012). Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells. FEBS Lett, 586, 1279-86. https://doi.org/10.1016/j.febslet.2012.03.006
- Guo X-G, Xia Y (2013). The interleukin-18 promoter-607C> A polymorphism contributes to nasopharyngeal carcinoma Risk: Evidence from a Meta-analysis Including 1, 886 Subjects. Asian Pac J Cancer Prev, 14, 7577-81. https://doi.org/10.7314/APJCP.2013.14.12.7577
- Iizasa H, Wulff BE, Alla NR, et al (2010). Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency. J Biol Chem, 285, 33358-70. https://doi.org/10.1074/jbc.M110.138362
- Iorio MV, Croce CM (2012). microRNA involvement in human cancer. Carcinogenesis, 33, 1126-33. https://doi.org/10.1093/carcin/bgs140
- Jiang M, Zhang P, Hu G, et al (2013). Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients. Mol Cell Biochem, 383, 67-75. https://doi.org/10.1007/s11010-013-1755-y
- Kozubek J, Ma Z, Fleming E, et al (2013). In-depth characterization of microRNA transcriptome in melanoma. PLoS One, 8, 72699. https://doi.org/10.1371/journal.pone.0072699
- Larne O, Martens-Uzunova E, Hagman Z, et al (2013). miQ--a novel microRNA based diagnostic and prognostic tool for prostate cancer. Int J Cancer, 132, 2867-75. https://doi.org/10.1002/ijc.27973
- Lauvrak S U, Munthe E, Kresse S H, et al (2013). Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes. Br J Cancer, 109, 2228-36. https://doi.org/10.1038/bjc.2013.549
- Lebanony D, Benjamin H, Gilad S, et al (2009). Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol, 27, 2030-7. https://doi.org/10.1200/JCO.2008.19.4134
- Lee N, Xia P, Quivey J M, et al (2002). Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys, 53, 12-22. https://doi.org/10.1016/S0360-3016(02)02724-4
- Li MY, Liu JQ, Chen DP, et al (2014). Glycididazole sodium combined with radiochemotherapy for locally advanced nasopharyngeal carcinoma. Asian Pac J Cancer Prev, 15, 2641. https://doi.org/10.7314/APJCP.2014.15.6.2641
- Li T, Chen J X, Fu X P, et al (2011). microRNA expression profiling of nasopharyngeal carcinoma. Oncol Rep, 25, 1353-63.
- Lin JC, Chiang CF, Wang SW, et al (2014). Significance of Expression of Human METCAM/MUC18 in Nasopharyngeal Carcinomas and Metastatic Lesions. Asian Pac J Cancer Prev, 15, 245-52. https://doi.org/10.7314/APJCP.2014.15.1.245
- Liu N, Chen N Y, Cui R X, et al (2012). Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol, 13, 633-641. https://doi.org/10.1016/S1470-2045(12)70102-X
- Liu N, Cui R X, Sun Y, et al (2014). A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma. Int J Cancer, 134, 1359-68. https://doi.org/10.1002/ijc.28468
- Liu N, Tang L L, Sun Y, et al (2013a). MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma. Cancer Lett, 329, 181-8. https://doi.org/10.1016/j.canlet.2012.10.032
- Liu X, Luo H N, Tian W D, et al (2013b). Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma. Cancer Biol Ther, 14.
- Lo A K, Dawson C W, Jin D Y, et al (2012). The pathological roles of BART miRNAs in nasopharyngeal carcinoma. J Pathol, 227, 392-03. https://doi.org/10.1002/path.4025
- Long J, Wang Y, Wang W, et al (2010). Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J Biological Chemis, 285, 23457-65. https://doi.org/10.1074/jbc.M110.136168
- Lu J, Getz G, Miska E A, et al (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834-8. https://doi.org/10.1038/nature03702
- Luo W R, Gao F, Li S Y, et al (2012). Tumour budding and the expression of cancer stem cell marker aldehyde dehydrogenase 1 in nasopharyngeal carcinoma. Histopathology, 61, 1072-81. https://doi.org/10.1111/j.1365-2559.2012.04350.x
- Ma F, Zhang J, Zhong L, et al (2014). Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/beta-catenin signaling. Gene, 535, 191-7. https://doi.org/10.1016/j.gene.2013.11.035
- Marquitz A R, Raab-Traub N (2012). The role of miRNAs and EBV BARTs in NPC. Semin Cancer Biol, 22, 166-72. https://doi.org/10.1016/j.semcancer.2011.12.001
- Qiu J, Cosmopoulos K, Pegtel M, et al (2011). A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. PLoS Pathog, 7, 1002193. https://doi.org/10.1371/journal.ppat.1002193
- Raab-Traub N, Flynn K, Pearson G, et al (1987). The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. Int J Cancer, 39, 25-29. https://doi.org/10.1002/ijc.2910390106
- Sarver A L, Li L, Subramanian S (2010). MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. Cancer Res, 70, 9570-80. https://doi.org/10.1158/0008-5472.CAN-10-2074
- Schetter A J, Harris C C (2011). Alterations of microRNAs contribute to colon carcinogenesis. Semin Oncol, 38, 734-72. https://doi.org/10.1053/j.seminoncol.2011.08.009
- Shanmugaratnam K, 1991, Histological typing of tumours of the upper respiratory tract and ear. World Health Organization International Histological Classification of Tumours. Springer-Verlag, Berlin, p. 32-34 pp.
- Sun XJ, Liu H, Zhang P, et al (2013). miR-10b promotes migration and invasion in nasopharyngeal carcinoma cells. Asian Pac J Cancer Prev, 14, 5533-37. https://doi.org/10.7314/APJCP.2013.14.9.5533
- Tsuchiyama K, Ito H, Taga M, et al (2013). Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer. Prostate, 73, 827-34. https://doi.org/10.1002/pros.22626
- Wolf H, Zur Hausen H, Klein G, et al (1975). Attempts to detect virus-specific DNA sequences in human tumors. III. Epstein-Barr viral DNA in non-lymphoid nasopharyngeal carcinoma cells. Med Microbiol Immunol, 161, 15-21. https://doi.org/10.1007/BF02120766
- Xi Y, Nakajima G, Gavin E, et al (2007). Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA, 13, 1668-74. https://doi.org/10.1261/rna.642907
- Xiao Z G, Deng Z S, Zhang Y D, et al (2013). Clinical significance of microRNA-93 downregulation in human colon cancer. Eur J Gastroenterol Hepatol, 25, 296-01. https://doi.org/10.1097/MEG.0b013e32835c077a
- Xie L, Yang Z, Li G, et al (2013). Genome-wide identification of bone metastasis-related microRNAs in lung adenocarcinoma by high-throughput sequencing. PLoS One, 8, 61212. https://doi.org/10.1371/journal.pone.0061212
- Yang H J, Huang T J, Yang C F, et al (2013). Comprehensive profiling of Epstein-Barr virus-encoded miRNA species associated with specific latency types in tumor cells. Virol J, 10, 314. https://doi.org/10.1186/1743-422X-10-314
- Yang I P, Tsai H L, Hou M F, et al (2012). MicroRNA-93 inhibits tumor growth and early relapse of human colorectal cancer by affecting genes involved in the cell cycle. Carcinogenesis, 33, 1522-30. https://doi.org/10.1093/carcin/bgs166
- Zheng G, Wang H, Zhang X, et al (2013). Identification and validation of reference genes for qPCR detection of serum microRNAs in colorectal adenocarcinoma patients. PLoS One, 8, 83025. https://doi.org/10.1371/journal.pone.0083025
- Zhi F, Cao X, Xie X, et al (2013). Identification of circulating MicroRNAs as potential biomarkers for detecting acute myeloid leukemia. PloS one, 8, 56718. https://doi.org/10.1371/journal.pone.0056718
Cited by
- MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma vol.16, pp.1, 2016, https://doi.org/10.1186/s12885-016-2525-5
- MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations vol.37, pp.5, 2016, https://doi.org/10.1007/s13277-015-4550-4
- miR-183 and miR-21 expression as biomarkers of progression and survival in tongue carcinoma patients pp.1436-3771, 2017, https://doi.org/10.1007/s00784-017-2126-y
- Dynamic Changes in Plasma MicroRNAs Have Potential Predictive Values in Monitoring Recurrence and Metastasis of Nasopharyngeal Carcinoma vol.2018, pp.2314-6141, 2018, https://doi.org/10.1155/2018/7329195
- pp.1555-8576, 2018, https://doi.org/10.1080/15384047.2018.1450112
- Identification of four plasma microRNAs as potential biomarkers in the diagnosis of male lung squamous cell carcinoma patients in China vol.7, pp.6, 2018, https://doi.org/10.1002/cam4.1490
- Circulating MicroRNAs in Young Patients with Acute Coronary Syndrome vol.19, pp.5, 2018, https://doi.org/10.3390/ijms19051467
- A novel and non-invasive approach utilising nasal washings for the detection of nasopharyngeal carcinoma pp.00207136, 2019, https://doi.org/10.1002/ijc.32173